Tumor growth leads to an increased "rate" of "de novo" synthesis and turnover of membrane lipids, and thousands of these lipid molecules play important roles in biological process such as the signaling and metabolic pathways 1, 2 . Alterations in membrane lipid components can change the activity of membrane proteins that serve as ion channels, transporters, receptors, signal transducers, and enzyme activity 3 and deeply influence cellular functions 4 . The phenomena linked to changes in cell membrane are suspected to play important roles during cancer transformation. Therefore, the determination of the membrane lipid components of tumor cells is essential in understanding tumor biological properties. Three main lipid species exist in mammalian cells, including glycerol-based lipids, cholesterol, and ceramide-based sphingolipids. Moreover, substantial studies in human cancers, such as colorectal 5 , lung 6 , liver 7 , and breast cancers [8] [9] [10] 
, and phosphatidylinositols (PIs), which are located on the cytoplasmic face of the membrane, participate in cell signaling and vesicle formation 2 . Decreased level of PI(18:0/18:1) in non-malignant cells relative to human breast cancer cell lines was also detected 8 . Sphingomyelins (SMs) were closely related to cell membrane fluidity 14 , and SMs and their metabolites also influenced the survival and migration of cancer cells 15 . Previous study has indicated that the ratio of total FAs to total unsaturated FAs was closely correlated with metastatic ability 9 . Recently, mass spectrometry-based approach for lipidomic analysis has provided a new platform for quantitative, qualitative, and functional studies of individual lipid species in cells, tissues, or biological fluids 16 , and plant metabolism 17 . Especially, matrix-assisted laser desorption/ionization (MALDI) mass spectrometry has shown the capability to in situ detect rapidly multiple cancer-specific lipid changes 18 . Recently, several MALDI matrices have been applied to the detection of small molecules, such as 1, 8-bis(dimethylamino)naphthalene (DMAN) for FAs analysis 19 and 2,5-dihydroxybenzoic acid (DHB) for PCs and SMs analysis.
In this study, we have directly performed membrane lipid profiling of one human mammary epithelial MCF-10A cells and six different breast cancer cell lines (i.e., BT-20, MCF-7, SK-BR-3, MDA-MB-231, MDA-MB-157, and MDA-MB-361) using MALDI-Fourier transform ion cyclotron resonance mass spectrometry (FTICR MS) to investigate the associations of membrane lipid components with their metastatic ability. Our data indicate that differences in the levels of the membrane lipids, such as PCs, SMs, FAs, PEs, and PIs, could be used to differentiate the above-mentioned seven cell lines, and that the unsaturated degree of these lipids might be correlated with the types of breast cancer cells.
Results
Differences in lipid levels of seven different breast cell lines. In this study, an untargeted membrane lipid profiling was performed to in situ analyze intact cell samples using MALDI-FTICR MS platform. Representative mass spectra of MCF-10 A cells are shown in Fig. 1 . Finally, a total of 180 membrane lipids including 69 detected in the positive ion mode and 111 detected in the negative ion mode were observed in seven different breast cell lines, and the detailed information on their m/z values are listed in Supplementary Table S1 . PLS-DA score plot revealed the obvious differences between control (MCF-10A) and six different breast cancer cell lines (BT-20, MCF-7, SK-BR-3, MDA-MB-231, MDA-MB-157, and MDA-MB-361), with the predicted residual sum of square (PRESS) of 0.1697 ( Fig. 2A) , and 46 lipids have the variable importance in the projection (VIP) values of > 1.0 (Supplementary Table S2 ). It should be noted that 8 simultaneously up-or down-regulated lipids in breast cancer cells relative to control were observed, and they are PC(32:1), SM(34:0), C 22:4 , PC(38:4), PI(38:4), PC(30:0), C 18:2 , and C 16:1 . The detailed information on their identification is shown in Supplementary Fig. S1 and Table S3 . As shown in Fig. 2B , the levels of PC(32:1), PC(30:0), and C 16:1 in breast cancer cells were significantly up-regulated, while the levels of SM(34:0), PC(38:4), PI(38:4), C 18:2 , and C 22:4 in breast cancer cells were remarkably down-regulated relative to control. Their detailed change trends are shown in Supplementary Fig. S2A .
PLS-DA core plot of 180 common membrane lipids from six different breast cancer cell lines could generate six obvious clusters, with the PRESS of 0.1885 (Fig. 2C) . BT-20 (ER-/PR-) cells derived from a primary tumor 20 was located in the lower left hand quadrant, MCF-7 (ER+ /PR+ ) cells from a metastatic tumor with a weakly invasive ability was in the lower right hand quadrant, highly invasive MDA-MB-231 (ER-/PR-) cells 21, 22 and MDA-MB-157 (ER-/PR-) cells 23 derived from metastatic pleural effusions of human breast carcinoma were found in the upper left hand quadrant, and MDA-MB-361 (ER+ /PR+ ) cells from a brain metastasis with weakly luminal epithelial-like phenotype 24 were found in the upper right hand quadrant. Interestingly, SK-BR-3 (ER-/PR-) cells with weakly luminal epithelial-like phenotype 20 were located at the right side of horizontal axis. It was found that a total of 49 lipids with the VIP values of > 1.0 have contributed to characterize their differences. The detailed information on their identification is shown in Supplementary Table S3 . Most importantly, 15 important lipids which mainly contributed to differentiate six different breast cancer cell lines were selected, and they are PE(38:4), PE(P-38: Hierarchical cluster analysis for the lipids of interest was described that used 'Ward' s linkage' algorithms to arrange lipids according to similarity measure. As shown in and PC(30:0)), detailed cluster analysis has further showed obvious associations of the their expression levels with the types of breast cell lines (Fig. 4B ). In addition, a heatmap of 8 FAs has indicated that their levels were also associated with the types of different breast cell lines (Fig. 4C ).
Association of expression levels of FASN1, SCD1, SCD5, CKα, and SMS1 with the types of breast cells. To determine the link of the expression levels of lipogenesis-related enzymes with the types of breast cells, the expression of FASN1, SCD1, SCD5, CKα , and SMS1 in seven different breast cell lines were detected using Western blotting. As shown in Fig. 5 and Supplementary Table S12, significantly increased levels of FASN1 in BT-20, MCF-7, SK-BR-3, and MDA-MB-361were detected relative to MCF-10A, MDA-MB-231, and MDA-MB-157. It should be noted that the SCD1 level in MCF-7 was significantly increased relative to other six breast cell lines (p < 0.001), while difference in the SCD1 level in 
Discussion
Conventional lipidomic analytical approaches usually involve a complex sample preparation, including lipid extraction, separation by chromatography followed by mass spectrometric detection. In this study, mass spectrometry profiling was performed to in situ detect membrane lipids of seven breast cell lines without any lipid extraction and separation. It was found that direct biological analysis not only maintained cell integrity but also contributed to obtain rapidly lipid profiles. In addition, the application of FTICR MS could offer ultrahigh accurate mass measurements 25 . Finally, we have observed 180 common membrane lipids in seven different breast cell lines (Supplementary Table S1 ). In addition, 23 Supplementary Table S12. PE Supplementary Fig. S2 .
PLS-DA score plot has revealed that a combination of 8 membrane lipids (i.e., PC(32:1), SM(34:0), C 22:4 , PC(38:4), PI(38:4), PC(30:0), C 18:2 , and C 16:1 ) could be used to obviously differentiate non-malignant human breast epithelial cells from six different breast cancer cell lines, suggesting that differences in membrane lipid components between non-malignant cells and malignant cells exist, and that significantly increased polyunsaturated lipids (i.e., C 22:4 , PC(38:4), PI(38:4), and C 18:2 ,) in the non-malignant cells relative to the malignant cells revealed the close link of the unsaturated degree of membrane lipids with the types of breast cancer cells. In addition, PLS-DA score plot of 180 lipids from six different breast cancer cell lines has remarkably classified them into six clusters (Fig. 2C) , indicating that the membrane lipid components of six different breast cancer cells might also reflect differences in their membrane components. It is worth noting that the highest expression of polyunsaturated lipids (i.e., PE(38:4), PE(P-38:5), PE(36:4), and C 20:4 ) in BT-20 cell membrane from a primary tumor, along with a weakly invasive ability and negative for estrogen and progesterone receptors were observed relative to other five breast cancer cell lines derived from metastatic breast cancer tumors (Fig. 2D) 
20
, indicating that the unsaturated degree of membrane lipids are closely associated with the types of breast cancer cells.
Substantial studies have indicated that FASN as a key enzyme in lipogenesis catalyzes de novo synthesis of palmitate (C 16:0 ) from acetyl-CoA, and that the over-expression of FASN can suppress tumor necrosis factor-α production 26 and contribute to poor prognosis in various types of cancer 27, 28 . As shown in Fig. S3 ). One reason may be that free C 16:0 and C 18:0 in cells are usually located in cytoplasm, and they are difficultly detected by mass spectrometry and another reason may be that they are rapidly consumed to generate membrane lipids (e.g. PC(30:0) and PC(32:1)) or converted to other long-chain FAs by elongases and desaturases 29 , resulting in an increase in the levels of lipids (e.g. PC (34:1), PI(34:1) and PI(36:1)). Thus, the over-expression of FASN1 in cancer cells sustains an increasing demand for saturated and monounsaturated lipids during cell proliferation. It was found that the levels of polyunsaturated species (e.g., PC(38:4) and PI(38:4) ) were down-regulated in most cancer cells. Some polyunsaturated FAs (e.g. C 22:6 and C 20:5 ) have been recognized as potential adjuvants against breast cancer cell proliferation, migration, and invasion 30 . SCDs mainly catalyze the synthesis of C 16:1 and C 18:1 from C 16:0 and C 18:0 , respectively. Previous studies have indicated that SCD1 (one isoform of SCD) played an important role in cancer progression 31 . In this study, it is found that high expression of SCD1 was detected in MCF-7 relative to BT-20, SK-BR-3, MDA-MB-231, MDA-MB-157, and MDA-MB-361 (Fig. 5C ), which is in agreement with the high ratios of C 16:1 /C 16:0 and C 18:1 /C 18:0 (Fig. 6) , and that significant increase in the SCD5 level (another isoform of SCD) in SK-BR-3 and MDA-MB-231cells might be another factor to increase the ratios of C 16:1 /C 16:0 and/ or C 18:1 /C 18:0 , but we could not explain what caused the high ratio of C 16:1 /C 16:0 in MDA-MB-361 cells (Fig. 6 ), which may be associated with other SCD enzymes.
PCs can be synthesized through cytidine diphosphate-choline pathway and choline kinase (CK) catalyzes the first step reaction in the choline pathway for de novo synthesis of PCs 32 . It was found that CKα , one isoform of CKs, was associated with the uncontrolled growth of cancer cells 33 . Our findings indicate that increased CKα level in BT-20, MCF-7, SK-BR-3, and MDA-MB-231 cells could lead to generate higher levels of PC(28:0), PC(30:0) and PC(32:1) relative to MCF-10 A cells (Supplementary Fig. S2 ). Specifically for MDA-MB-231 cells, it is found that the highest CKα level (Fig. 5E ) was remarkably associated with the highest level of PC(36:1) and PC(36:2) relative to other six different breast cells. In the Golgi apparatus, SMS1 can utilize PC species as its substrate to produce SMs 34 . In this study, it is worth noting that the expression level of SMS1 in BT-20, MCF-7, SK-BR-3, and MDA-MB-361 (Fig. 5F ) was positively and closely correlated to change in the SM(34:1) level, specially for MDA-MB-361, but not related to the SM(34:0) level.
Gene microarray analysis is often used to be diagnostic biomarkers and distinguish metastatic ability of breast cancer cells 35 . Our results indicate that direct membrane lipid profiling coupled with the expression detection of lipogenesis-related enzymes may provide another insight to understand differences in molecular mechanisms of different breast cells, and to help distinguish different breast cell lines. (Fig. 6) . BT-20 cells can generate the high levels of PE(38:4), PE(P-38:5), and PE(36:4) relative to other breast cancer cells.
Altogether, the correlations of changes in the levels of membrane lipids with the expression levels of five lipogenesis-related enzymes of six different breast cancer cell lines are shown in Fig. 7 . It is found that polyunsaturated lipids in cancer cell membrane from a primary tumor, such as BT-20, were significantly increased relative to other five breast cancer cell lines from metastatic breast cancer tumors. It is worth noting that polyunsaturated lipids in breast cell membrane were really synthesized by themselves, not from exogenous fat, and that the unsaturated degree of membrane lipids for highly invasive breast cancer cells from metastatic breast cancer tumors was significantly decreased relative to healthy cells or breast cancer cells from a primary tumor. Most importantly, our results indicate that the membrane lipid phenotype and lipogenesis-related enzymes of breast cell lines might be associated with their malignancy. It should be noted that in this study some questions still remain unanswered, including the relationships between changes in the levels of membrane lipids, the lipogenesis-related protein expression, and cell properties for seven different cell lines. Further studies are need to determine these associations for each individual cell lines, such as by the addition of different exogenous lipids as cell food 36 .
Conclusions
In this study, we have performed an in situ detection of membrane lipid profiles of seven different breast cell lines using an ultrahigh resolution MALDI-FTICR MS, without the requirement of separation and extraction process prior to mass spectrometric analysis. Our data show that a combination of 8 lipids could differentiate non-malignant MCF-10A cells from six different breast cancer cell lines and that a combination of 15 lipids could differentiate six different breast cancer cells. It is worth noting that significantly increased levels of monounsaturated lipids might be associated with the malignant degree of breast cancer cells. In addition, the presence of the high levels of polyunsaturated lipids in MCF-10A and BT-20 cell membranes relative to MCF-7, SK-BR-3, MDA-MB-231, MDA-MB-157, and MDA-MB-361 strongly suggest that polyunsaturated FAs were self-synthesized, not from dietary fat intake. All media were supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics (100 U/mL penicillin and 100 μ g/mL streptomycin). Two conductive indium tin oxide (ITO)-coated glass slides were placed at the bottom of each of 100-mm culture dishes and cells were seeded in these dishes 37 , followed by the incubation until 80% confluence. All experiments were performed in accordance with relevant guidelines and regulations.
Cell sample preparation. Cell-coated ITO-glass slides were washed with phosphate buffer saline three times and then air-dried. Matrix sublimation deposition was performed as our own previous study 38 . Briefly, the cell-coated ITO-slide was mounted onto the bottom of the condenser using thermally conductive double-sided adhesive tape and the slide was kept at approximately 4 °C using a water cooling system. 10 mg of DHB (Sigma-Aldrich, St. Louis, MO, USA) was sublimed under a fixed vacuum Supplementary Table S4 and S12.
Scientific RepoRts | 5:11298 | DOi: 10.1038/srep11298 of 5 mTorr at an optimized sublimation temperature of 120 °C for 20 min. Finally, approximately 3.5 mg of DHB was coated at the surface of one cell-coated ITO-slide followed by mass spectrometric analysis in a positive ion mode. 20 mg of DMAN (Sigma-Aldrich, St. Louis, MO, USA) was sublimed under the above-mentioned vacuum condition at 50 °C for 9 min, and approximately 7.2 mg of DMAN was coated at the surface of another cell-coated ITO-slide from the same dish for mass spectrometric analysis in a negative ion mode. Each of the matrix-coated slide was placed at -20 °C for 30 min, and then the recrystallization was performed in a Petri dish (100 mm diameter × 15 mm depth) at a saturated solution atmosphere of methanol/water (1:1, v/v).
Mass spectrometry profiling.
All experiments were performed using a 9.4 T Apex-ultra + ions in the positive ion mode were further combined as one variable. The peaks observed at least in two-thirds of seven cell lines were selected, and the half of the baseline strength in each spectrum was adopted as their intensities of missing lipids. Finally, the resulting datasets were exported to Microsoft Excel. The intensities of lipids (or variables) from each mass spectrum were normalized to a constant number of 1000. Resulting datasets in the positive and negative ion modes were further combined into one dataset before statistical analysis.
Partial least-square discriminant analysis (PLS-DA) was performed to evaluate differences between control and different breast cancer cell lines. Univariate analysis was performed using non-parametric Wilcoxon-Mann-Whitney test. Correlation and cluster analysis were performed to analyze the correlation between saturated and unsaturated lipids. A p value of < 0.05 was considered as statistically significant. Statistical analyses were performed using SAS software (version 9.2, SAS Institute Inc.) and SPSS software (version 16.0, SPSS Inc., Chicago, IL).
Identification of membrane lipids of interest.
Significantly changed lipids were identified as our own previous studies 38, 39 . Briefly, lipids were identified with the aid of the available databases (the Lipid maps (http://www.lipidmaps.org/) and the METLIN database (http://metlin.scripps.edu/)), as well as their observed accurate m/z values relative to theoretical vales of < 2 ppm, isotopic abundance distribution relative to theoretical distribution of < 5%, and tandem mass spectra.
Western blotting. Cells were harvested and suspended in RIPA lysis buffer (Solarbio Science & Technology Co., Beijing, China) which contains an antiprotease cocktail. After centrifugation, the amount of proteins in the supernatant was determined using bicinchoninic acid protein assay. Five aliquots of total proteins (30 mg) from each cell line were isolated by SDS-PAGE followed by transferring onto a polyvinylidene fluoride microporous membrane, respectively. These membranes were blocked with 5% (w/v) non-fat powdered milk in Tris-buffered saline plus 0.1% Tween-20 for 2 h at room temperature, and then incubated overnight at 4 °C with CKα -, SMS1-, SCD1-, SCD5-, and FASN1-specific antibodies (Abcam, San Francisco, CA, USA), respectively. These membranes were assayed against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as loading control. Secondary goat anti-mouse (Southern Biotechnology Assoc., Asbach, Germany) or goat anti-rabbit (Abcam) antibodies were used at a dilution of 1:2000 with the incubation for 2 h at room temperature. Signals were detected by chemiluminescent HRP substrate (Millipore, Billerica, MA, USA) and images were acquired using ImageQuant TM LAS 4000 mini (GE Healthcare Uppsala, Sweden). The chemiluminescent signals were quantified using Quantity One software (Bio-Rad Laboratories) and were normalized to GAPDH, respectively.
One-way analysis of variance (ANOVA) was performed to determine statistically significant differences between non-malignant control and six different breast cancer cell lines. A p value of < 0.05 was considered as statistically significant.
